Inflammation Intensity–Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Arthritis & Rheumatology

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/art.40468PMID 29481736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis

  2017cited by this paper
• Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis

  2016cited by this paper
• Ankylosing Spondylitis and Axial Spondyloarthritis.

  2016cited by this paper
• Molecular mechanisms of bone formation in spondyloarthritis.

  2016cited by this paper
• Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes

  2016cited by this paper
• Ankylosing Spondylitis and Axial Spondyloarthritis.

  2016cited by this paper
• Health and imaging outcomes in axial spondyloarthritis

  2016cited by this paper
• Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo.

  2015cited by this paper
• Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

  2015cited by this paper
• Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression

  2015cited by this paper
• Pelvic retroversion is the key protective mechanism of L4–5 degenerative spondylolisthesis

  2015cited by this paper
• Role of Enhanced Central Leptin Activity in a Scoliosis Model Created in Bipedal Amputated Mice

  2015cited by this paper
• Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis

  2015cited by this paper
• LIM Mineralization Protein‐1 Enhances Bone Morphogenetic Protein‐2–Mediated Osteogenesis Through Activation of ERK1/2 MAPK Pathway and Upregulation of Runx2 Transactivity

  2015influential reference
• Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: Decreased expression of this receptor in nonclassical monocytes

  2014cited by this paper
• Non-canonical Wnt4 prevents skeletal aging and inflammation by inhibiting NF-κB

  2014cited by this paper
• Wnt signaling in ankylosing spondylitis

  2014cited by this paper
• Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression

  2014cited by this paper
• Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells

  2013cited by this paper
• Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis

  2013cited by this paper
• Expression profiling in spondyloarthropathy synovial biopsies highlights changes in expression of inflammatory genes in conjunction with tissue remodelling genes

  2013cited by this paper
• Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells.

  2013cited by this paper
• Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis

  2013cited by this paper
• Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

  2012cited by this paper
• Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis”

  2012cited by this paper
• Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

  2012cited by this paper
• Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors

  2012cited by this paper
• Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis

  2012cited by this paper
• Inflammation and ankylosis: still an enigmatic relationship in spondyloarthritis

  2012cited by this paper
• Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis

  2012cited by this paper
• Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells

  2011cited by this paper
• Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study

  2011cited by this paper
• TNF-α and IL-1β Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation through Syndecan-4 in Intervertebral Disc*

  2011cited by this paper
• Activation of c‐Jun NH2‐terminal kinase 1 increases cellular responsiveness to BMP‐2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor

  2011cited by this paper
• Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.

  2011cited by this paper
• MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis

  2011cited by this paper
• Resolution of Inflammation Following Treatment of Ankylosing Spondylitis Is Associated with New Bone Formation

  2011cited by this paper
• High levels of β‐catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway

  2011cited by this paper
• Osteoinductive LIM mineralization protein-1 suppresses activation of NF-kappaB and selectively regulates MAPK pathways in pre-osteoclasts.

  2010cited by this paper
• Pathogenesis of ankylosing spondylitis

  2010cited by this paper
• Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.

  2010cited by this paper
• Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation.

  2009cited by this paper
• Animal models of spondyloarthritis.

  2009cited by this paper
• Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.

  2009cited by this paper
• Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

  2009cited by this paper
• Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

  2009cited by this paper
• The Natural Course of Radiographic Progression in Ankylosing Spondylitis — Evidence for Major Individual Variations in a Large Proportion of Patients

  2009cited by this paper
• Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

  2008cited by this paper
• Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells

  2008cited by this paper
• Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

  2008cited by this paper
• Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.

  2008cited by this paper
• Dickkopf-1 is a master regulator of joint remodeling

  2007cited by this paper
• Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.

  2007cited by this paper
• Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation.

  2007cited by this paper
• A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation

  2007cited by this paper
• Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.

  2007cited by this paper
• Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of p38 MAPK*

  2007cited by this paper
• Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis.

  2006cited by this paper
• Animal models of spondyloarthritis

  2006cited by this paper
• Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.

  2005cited by this paper
• A longitudinal study on an autoimmune murine model of ankylosing spondylitis

  2005cited by this paper
• Radiographic progression in patients with ankylosing spondylitis after two years of treatment with the tumor necrosis factor-α antibody infliximab

  2005cited by this paper
• Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.

  2005cited by this paper
• Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.

  2004cited by this paper
• Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis

  2004cited by this paper
• Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

  2004cited by this paper
• Dependence on interferon-gamma for the spontaneous occurrence of arthritis in DBA/1 mice.

  2003cited by this paper
• Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow.

  2000cited by this paper
• Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.

  1998cited by this paper
• Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice

  1992cited by this paper
• Experimental structural scoliosis.

  1987cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper
• The pathogenesis of ankylosing spondylitis.

  1975cited by this paper
• Experimental progressive scoliosis in the rabbit.

  1961cited by this paper

• A novel mouse model of arthritis with enthesitis and heterotopic ossification.

  2026cites this paper
• Clinical Characteristics and a New Classification System of Mono‐Segmental Thoracic and Lumbar Nonfusion in Patients With Ankylosing Spondylitis

  2026cites this paper
• Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

  2025cites this paper
• Erosive costovertebral joint arthritis as a novel feature of ankylosing spondylitis

  2025cites this paper
• Advancing precision medicine in axial spondyloarthritis: insights from multi-omics approaches

  2025cites this paper
• Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation

  2025cites this paper
• Lithium chloride modulates macrophage polarization and enhances bone defect healing in the induced membrane technique by activation of Wnt/β-catenin signaling

  2025cites this paper
• Upregulated GDF‐15 in Ankylosing Spondylitis: Pathologic Ossification Promotion through Ligament Fibroblast Osteogenic Differentiation

  2025cites this paper
• Promoter Methylation of WIF1 is Involved in IL-17-Induced Chondrocyte Inflammatory Injury and Matrix Degradation via Promoting Wnt5a/MAPK-JNK Signaling.

  2025cites this paper
• IL‐33‐Induced TREM2+ Macrophages Promote Pathological New Bone Formation Through CREG1‐IGF2R Axis in Ankylosing Spondylitis

  2025cites this paper
• Acupuncture Treatment May Improve the Bone Metabolism and Pathological Ossification by Regulating the Gut Microbiota of AS Mice.

  2025cites this paper
• Aberrant DNA Methylation Profile of Dickkopf-1 in Ankylosing Spondylitis

  2024cites this paper
• Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis – SPARTAN 2024 Annual Meeting Proceedings

  2024cites this paper
• Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation

  2024influential citation
• Extracellular Vesicles Derived from Ligament Tissue Transport Interleukin‐17A to Mediate Ligament‐To‐Bone Crosstalk in Ankylosing Spondylitis

  2024cites this paper
• Investigation of the Shared Biomarkers in Heterotopic Ossification Between Ossification of the Ligamentum Flavum and Ankylosing Spondylitis

  2024cites this paper
• miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markers.

  2024cites this paper
• Intermittent administration of PTH for the treatment of inflammatory bone loss does not enhance entheseal pathological new bone formation.

  2024cites this paper
• Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential

  2024cites this paper
• The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review

  2024cites this paper
• Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings

  2024cites this paper
• Purine metabolites promote ectopic new bone formation in ankylosing spondylitis.

  2023cites this paper
• Osteoimmunology: Interactions With the Immune System in Spinal Fusion

  2023cites this paper
• PRICKLE1 gene methylation and abnormal transcription in Chinese patients with ankylosing spondylitis.

  2023cites this paper
• Impact of immune regulation and differentiation dysfunction of mesenchymal stem cells on the disease process in ankylosing spondylitis and prospective analysis of stem cell transplantation therapy.

  2023cites this paper
• Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization

  2023cites this paper
• IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health

  2023cites this paper
• Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study

  2023influential citation
• A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation

  2023cites this paper
• Chronic arthritides and bone structure: focus on rheumatoid arthritis—an update

  2023cites this paper
• Tumor-derived extracellular vesicles delivering TNF-α promotes colorectal cancer metastasis via the NF-kB/LAMB3/AKT axis by targeting SNAP23.

  2023cites this paper
• Rotating Magnetic Field Mitigates Ankylosing Spondylitis Targeting Osteocytes and Chondrocytes via Ameliorating Immune Dysfunctions

  2023cites this paper
• MYC promotes fibroblast osteogenesis by regulating ALP and BMP2 to participate in ectopic ossification of ankylosing spondylitis

  2023cites this paper
• Deciphering in vivo metabolic profile and pharmacological mechanisms of Jitongning Tablet for the treatment of Ankylosing spondylitis.

  2023cites this paper
• Transfer of microRNA-22-3p by M2 macrophage-derived extracellular vesicles facilitates the development of ankylosing spondylitis through the PER2-mediated Wnt/β-catenin axis

  2022cites this paper
• Distribution of Acute and Chronic Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis

  2022cites this paper
• TNF-α Activating Osteoclasts in Patients with Psoriatic Arthritis Enhances the Recruitment of Osteoclast Precursors: A Plausible Role of WNT5A-MCP-1 in Osteoclast Engagement in Psoriatic Arthritis

  2022cites this paper
• STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis

  2022cites this paper
• CXCL12/CXCR4-Rac1–mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis

  2022cites this paper
• Wnt and Smad signaling pathways synergistically regulated the osteogenic differentiation of fibroblasts in ankylosing spondylitis.

  2022cites this paper
• DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17

  2022cites this paper
• Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis

  2022cites this paper
• Platelet‐Derived Growth Factor B Is a Key Element in the Pathological Bone Formation of Ankylosing Spondylitis

  2022cites this paper
• Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis

  2022cites this paper
• Gingival epithelial cell-derived microvesicles activate mineralization in gingival fibroblasts

  2021cites this paper
• Low expression of TCP1 (T-Complex 1) and PSMC1 (Proteasome 26S subunit, ATPase 1) in heterotopic ossification during ankylosing spondylitis

  2021cites this paper
• Immunopathophysiology of Juvenile Spondyloarthritis (jSpA): The “Out of the Box” View on Epigenetics, Neuroendocrine Pathways and Role of the Macrophage Migration Inhibitory Factor (MIF)

  2021cites this paper
• Tail suspension delays ectopic ossification in proteoglycan-induced ankylosing spondylitis in mice via miR-103/DKK1

  2021cites this paper
• New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

  2021cites this paper
• GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty

  2021cites this paper
• Gut microbiota-microRNA interactions in ankylosing spondylitis.

  2021cites this paper
• Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis

  2021cites this paper
• Navigating the diverse immune landscapes of psoriatic arthritis

  2021cites this paper
• Cytokine “fine tuning” of enthesis tissue homeostasis as a pointer to spondyloarthritis pathogenesis with a focus on relevant TNF and IL-17 targeted therapies

  2021cites this paper
• Regulation of bone mass in inflammatory diseases.

  2021cites this paper
• Anti-Osteogenic Effect of Danshensu in Ankylosing Spondylitis: An in Vitro Study Based on Integrated Network Pharmacology

  2021cites this paper
• The TNF-NF-kB-DKK1 Axis Promoted Bone Formation in the Enthesis of Ankylosing Spondylitis

  2021cites this paper
• Progression of axial spondyloarthritis

  2021cites this paper
• Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis

  2021cites this paper
• WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis

  2021influential citation
• Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches.

  2021cites this paper
• TNF-α activates WNT5A, which recruits osteoclast precursors by MCP-1 production, but not directly activates osteoclastogenesis, in psoriatic arthritis

  2021cites this paper
• LncRNA HOTTIP enhances human osteogenic BMSCs differentiation via interaction with WDR5 and activation of Wnt/β-catenin signalling pathway.

  2020cites this paper
• DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts

  2020cites this paper
• Clonorchis sinensis-Derived Protein Attenuates Inflammation and New Bone Formation in Ankylosing Spondylitis

  2020cites this paper
• Bone phenotypes in rheumatology – there is more to bone than just bone

  2020cites this paper
• STAT3 Phosphorylation Inhibition for Treating Inflammation and New Bone Formation in Ankylosing Spondylitis.

  2020cites this paper
• Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features?

  2020cites this paper
• Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis

  2020influential citation
• Refractory Psoriatic Arthritis Responding to an Increased Dose of the Anti-TNF Monoclonal Antibody Adalimumab

  2020cites this paper
• Establishment of an induced pluripotent stem cell line (SHFDi001-A) from a patient with ankylosing spondylitis.

  2020cites this paper
• MicroRNAs in ankylosing spondylitis: Function, potential and challenges

  2020cites this paper
• Advances on Wnt / β-catenin signaling pathway in osteogenesis of ankylosing spondylitis

  2019influential citation
• Wnt4 signaling mediates protective effects of melatonin on new bone formation in an inflammatory environment

  2019cites this paper
• Targeting inflammatory pathways in axial spondyloarthritis

  2019cites this paper
• Bone formation in axial spondyloarthritis: Is disease modification possible?

  2019cites this paper
• Gene–gene interaction and association of Wnt/Β-catenin signalling pathway gene polymorphisms with ankylosing spondylitis susceptibility in the Chinese Han population

  2019cites this paper
• Bilobalide alleviates IL‐17‐induced inflammatory injury in ATDC5 cells by downregulation of microRNA‐125a

  2019cites this paper
• MiR-495 targeting dvl-2 represses the inflammatory response of ankylosing spondylitis.

  2019cites this paper
• Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review

  2019cites this paper
• Spondyloarthritis: Low-level inflammation promotes bone growth

  2018cites this paper